HME Square has successfully concluded its exhibition at the 86th Annual Scientific Sessions of the American Diabetes Association (ADA 2026), held in New Orleans, Louisiana (June 5–8).

Marking our four consecutive year of participation since 2023, HME Square once again took the stage at one of the world's most prestigious diabetes conferences to showcase the latest advancements in our non-invasive glucose monitoring technology. Throughout the 4-day event, we engaged with leading diabetes experts, clinicians, and global industry partners, providing live demonstrations of our technology and receiving strong interest regarding its clinical potential and market readiness.

We extend our sincere gratitude to all the visitors, researchers, and partners who stopped by our booth. The continuous encouragement and technical feedback from the global community serve as a powerful driver for our ongoing R&D and commercialization milestones.

Following this success, HME Square will be participating in WHX OSAKA 2026 next month in July. We look forward to sharing further updates on our upcoming exhibition schedule and global progress as they are confirmed.